Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05505188
Other study ID # 2020-A01894-35
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date September 1, 2024

Study information

Verified date August 2022
Source University Hospital, Caen
Contact Maxime Humbert, MD
Phone 0231064640
Email humbert-m@chu-caen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Head and neck cancers are a source of complications and after-effects related to the disease and treatment. These cancers and their treatment alter the quality of life of patients and generate pain with physical and psychological components. Chronic pain affects 36% of patients at 6 months and 30% after this period. These pains are responsible for the consumption of level II and III analgesics in 53% of these patients. At the same time, after the end of treatment, nearly a quarter of patients continued to smoke and half still consumed alcohol at least twice a week. The hypothesis of this research is to investigate the correlation between pain and the continuation of addictions, the occurrence of depressive states, asthenia and the alteration of the patients' global quality of life. The investigators propose a two-center prospective cohort study to evaluate this hypothesis at 6 months after radiotherapy treatment. This study is planned to include 120 patients with a first head and neck cancer whit radiotherapy as part of their treatment sequence. The expected duration of inclusion is 18 months. The identification of factors affecting survival, quality of life and patient compliance is essential to determine appropriate management, particularly by creating appropriate therapeutic education programs.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date September 1, 2024
Est. primary completion date March 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with a first Head and neck cancer whose therapeutic sequence involves radiotherapy - Patient over 18 years of age - Having given written consent - patient not previously treated with radiotherapy - Life expectancy > 3 months - World Health Organization (WHO) score < 3 - Histologically proven Head and Neck cancer - Stable patient, with no signs of recurrence or other progressive neoplasia at the time of the examination - Patient treated with radiotherapy - Patient fluent in French Exclusion Criteria: - Non-consenting patient - History of malignancy, other than treated and cured basal cell or cervical cancer - Patient who has had a salvage surgery other than lymph node removal - Patient with evidence of recurrence or other progressive neoplasia at the time of examination - Patient who has had previous mutilating surgery (causing sequelae of swallowing and eating) - Uncontrolled infectious pathology - Patient under 18 years of age - Patient who is not fluent in French - Patient with a psychiatric pathology that could disrupt the study or prevent the interpretation of the results.

Study Design


Intervention

Other:
Questionnaire
Self-questionnaires are completed by the patient at the time of this consultation: Neuropathic pain: NPSI in screening Anxiety/depression: HADS in screening Quality of life: EORTC (QLQC30 and H&N43) Fatigue: MFI-20 hese self-questionnaires will be retrieved by the Clinical Research Associate (CRA) for verification. Depending on the result of the NPSI questionnaire can be completed to better characterize neuropathic pain. Depending on the result of the HADS, the MADRS questionnaire can be completed to quantify the degree of depression. Individuals diagnosed with neuropathic pain or other depressive symptoms during the 6-month inclusion period will be referred to and managed by specialized practitioners. This assistance will be indicated in follow-up report

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Caen Centre Francois Baclesse

Outcome

Type Measure Description Time frame Safety issue
Primary change, neuropathic pain 1 Neuropathic Pain Symptom Inventory (NPSI) questionnaire, score 0 to 10, higher scores mean a worse, score 0 to 100, higher scores mean a worse outcome Day 0", "Month 6"
Secondary change, anxiety/depression with Hospital Anxiety and Depression Scale (HADS), score 0 to 21, higher scores mean a worse outcome Day 0", "Month 6"
Secondary change, anxiety/depression 1 Montgomery and Asberg Depression Scale (MADRS) questionnaire, score 0 to 60, higher scores mean a worse outcome Day 0", "Month 6"
Secondary change, quality of life QLQC30 questionnaire of Quality of Life, score 30-100, higher scores indicating better outcomes. the questionnaire measures several factors: physical fitness, professional activity, pain, nutrition, secondary effect, psychological and social status. Day 0", "Month 6"
Secondary change, quality of life 1 H&N43 questionnaire of Quality of Life, score 43 to 172, higher scores indicating a worse outcomes. The questionnaire measures several factors:secondary effect, self-image, sociability, sexuality. Day 0", "Month 6"
Secondary change, fatigue Multidimensional Fatigue Inventory (MFI-20) questionnaire, score 20 to 100, high scores represent more fatigue Day 0", "Month 6"
Secondary change, symptoms related to head and neck cancer MD Anderson Symptom Inventory Head and Neck (MDASI-HN) questionnaire, score 0 to 220, higher scores indicating more symptoms Day 0", "Month 6"
Secondary change, sleep question about sleep quality 0-10, higher scores indicating better outcomes Day 0", "Month 6"
Secondary change, the impact of pain short pain questionnaire in French (QCD), score 0 to 120, high scores represent more impact of pain Day 0", "Month 6"
Secondary change, Alcohol Use and Consumption Disorder Diagnostic and statistical manual of mental disorders (5th ed.) (DSM5) , questionnaire, score 0 to 115, high scores represent more disorder Day 0", "Month 6"
Secondary change use of other psychoactive substances Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) alcool questionnaire, score 0 to 39, high scores represent more addiction Day 0", "Month 6"
Secondary change severity of nicotine addiction Fagerström questionnaire, score 0 to 10, high scores represent more addiction Day 0", "Month 6"
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT04513743 - Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ N/A
Completed NCT03251274 - Bath Machine on Sleep Quality in Nursing Home N/A
Completed NCT04102345 - Lavender vs Zolpidem Sleep Quality During Diagnostic PSG Early Phase 1
Completed NCT03725943 - Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT04562181 - Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index N/A
Completed NCT05102565 - A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers N/A
Completed NCT05576844 - Ai Youmian (Love Better Sleep) for People Living With HIV N/A
Completed NCT04688099 - Synovial Fluid Sleep Study
Recruiting NCT04171245 - Prescribing Laughter for Sleep and Wellbeing in UAE University Students N/A
Completed NCT03758768 - The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms N/A
Completed NCT03163498 - Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
Completed NCT04093271 - Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep Phase 1
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04120363 - Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations Phase 4